Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2025-12-24 @ 5:08 PM
NCT ID:
NCT03088150
Eligibility Criteria:
Most important inclusion criteria:
* At least one CRLM size ≤ 3 cm eligible for both surgical resection and thermal ablation (target lesions);
* Additional unresectable CRLM should be ≤ 3 cm and ablatable (unresectable lesions);
* Additional unablatable CRLM should be resectable (unablatable lesions);
* Maximum number of CRLM 10;
* Resectability and ablatability should be re-confirmed intra-operatively by US plus full exploration for hepatic, peritoneal and regional lymph node metastases;
* ASA 1-3.
Most important exclusion criteria:
* No target lesions suitable for both resection and ablation;
* Radical treatment unfeasible or unsafe (e.g. insufficient FLR);
* The presence of extrahepatic nodal or non-nodal metastases;
* Immunotherapy or chemotherapy ≤ 6 weeks prior to the procedure;
* Any surgical resection or focal ablative liver therapy for CRLM prior to inclusion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03088150
Study Brief:
Protocol Section:
NCT03088150